Pricing

Anthera Pharmaceuticals Inc (ANTH)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
John Craig Thompson
Employees:
20
25801 INDUSTRIAL BOULEVARD, SUITE B, HAYWARD, CA, 94545
(510) 856-5600

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Stock Split History
DateRatio
2013-07-15 1:8
2017-04-28 1:1
2017-05-01 1:8
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on developing and commercializing products to treat serious and life-threatening diseases, including lupus, lupus with glomerulonephritis, IgA nephropathy, and exocrine pancreatic insufficiency due to cystic fibrosis. It develops phase 3 product candidates, which includes blisibimod and liprotamase. Anthera Pharmaceuticals was founded by Paul F. Truex on September 9, 2004 and is headquartered in Hayward, CA.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available